Skip to content
  • About
  • Board
  • News
  • Sign Up
  • Contact

Visit

vjoncology logo
VJHemOnc
Logo
  • Home (current)
  • Diseases
    CLL
    Multiple Myeloma
    Myeloproliferative Neoplasms
    ALL
    AML
    Lymphoma
    View all Diseases
  • Topics
    Transplantation
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    View all Topics
  • Conferences
    MPN Advances Day
    2019
    iwCAR-T
    2019
    COSTEM
    2019
    ESMO
    2019
    iwCLL
    2019
    IMW
    2019
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

Enasidenib

1:27
Progress in AML & research at the University of Düsseldorf
Thomas Schröder
4:31
Personalized AML therapy with John Byrd: the beat AML trial and more
John Byrd
2:52
Ivosidenib or enasidenib with chemotherapy for AML produces deep remissions
Eytan Stein
2:25
Beat AML: promising results with enasidenib for AML in the frontline
Eytan Stein
1:25
IDH inhibitors for AML: highlights from ASH 2018
Marina Konopleva
1:51
IDH1/2 inhibitors for upfront AML therapy and transfusion independence
Amir Fathi
4:42
Gene-based treatments show positive outcomes in AML
Harry Erba
4:06
Gene-targeting therapies for AML
Harry Erba
1:53
The promising role of IDH inhibitors in AML
Amir Fathi
3:29
Novel drugs and targets in MDS
Valeria Santini
2:13
A success story: IDH inhibitors for AML
Alexander Perl
3:51
Changes in the AML treatment landscape
Richard Stone
4:14
Future therapies for AML: bispecifics and small molecule inhibitors
Farhad Ravandi
1:32
IDH inhibitors for AML and MDS
Eunice Wang
2:56
Newly approved drugs for AML in the US
Naval Daver
3:16
AML metabolism may be the key to successful treatment
Giovanni Martinelli
  • 1
  • 2
  • Next
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Continue

Please enter your details if you would like to receive the latest hemonc news and updates

Sign up
Disease Channels
  • CLL
  • Multiple Myeloma
  • Myeloproliferative Neoplasms
  • ALL
  • AML
  • Lymphoma
  • View all
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up
mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJHemOnc logo
The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy